Zonisamide - HY-B0124
10mM
Nur noch %1 verfügbar
Catalog #
HY-B0124
Ab
106,00 €
Zonisamide (AD 810) is an orally active carbonic anhydrase inhibitor, with Kis of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide can be used in studies of seizure, parkinson’s disease and cardiac hypertrophy[1][2][3][4].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-B0124/Zonisamide-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Neuroscience-Neurodegeneration |
| Alternative Names | AD 810; CI 912 |
| CAS | 68291-97-4 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 212.23 |
| Solubility | DMSO : 250 mg/mL (ultrasonic)|H2O : 0.67 mg/mL (ultrasonic) |
| Clinical Information | Launched |
| Target | Apoptosis;Carbonic Anhydrase |
| Application: | Neuroscience-Neurodegeneration |
|---|